FDA Issues 'Approvable Letter' For Boston Scientific Stent - WSJ.com: "March 18, 2008 1:43 p.m.
Boston Scientific Corp. now has a Food and Drug Administration 'approvable letter' for its Taxus Liberte drug-coated stent heart device, which has long been held back from the U.S. market by company regulatory issues, an official said Tuesday."
